The EngineConstitutional Accountability
Here: Constitutional AtlasStage: ObservationPerspective: EmployerDepth: Executive SummaryNext: UnderstandingReturn to the Constitution

Specialty 48

Medical Toxicology

Where you are

Medical Toxicology — Atlas

This specialty validates a distinct constitutional property of accountability (Volume II). Its canonical case, obligation architecture, and constitutional relationships are transcribed from the ratified specialty corpus.

Active constitutional concepts

  • Constitutional specialty
  • Canonical case
  • Constitutional property

Next: Review the canonical case and obligation architecture, then compare related specialties.

Back to the Atlas

Constitutional summary

Canonical case

Acetaminophen Overdose Without Demonstrable Completion of Serial Reassessment and Evidence-Based Antidote Discontinuation Obligations

Constitutional first cause

The Engine begins when: A known or suspected acetaminophen exposure reaches the threshold requiring toxicologic evaluation and possible acetylcysteine treatment. It should not begin only after liver injury appears. The exposure creates diagnostic, treatment, monitoring, and reassessment obligations before the final outcome is known.

Obligation architecture

  1. 1Event observed — Known or suspected acetaminophen overdose identified.
  2. 2Obligation 1 — Exposure reconstruction — Dose, timing, formulation, repeated use, co-ingestions, body weight, and relevant risk factors must be established as far as possible. — Evidence: patient history, medication containers, EMS record, pharmacy data, collateral history.
  3. 3Obligation 2 — Initial testing — Acetaminophen concentration and relevant hepatic and metabolic studies must be obtained at clinically appropriate times. — Evidence: laboratory timestamps, specimen records, hepatic tests, coagulation studies.
  4. 4Obligation 3 — Treatment threshold determination — The available facts must be applied to the appropriate toxicologic decision rule or clinical pathway. — Evidence: documented calculation, nomogram use where applicable, repeated-ingestion assessment, toxicology recommendation.
  5. 5Obligation 4 — Antidote initiation — Acetylcysteine must be started when indicated, including empirically when delay would create unacceptable risk. — Evidence: medication order, administration record, reason for initiation.
  6. 6Obligation 5 — Toxicology consultation or protocol ownership — A responsible clinician or poison-control/toxicology service must own ongoing interpretation where complexity warrants it. — Evidence: consultation, poison-center record, named treatment owner.
  7. 7Obligation 6 — Serial monitoring — Acetaminophen concentration, hepatic injury markers, coagulation status, clinical condition, and other applicable evidence must be reassessed. — Evidence: serial laboratory results, examination, mental-status record, metabolic studies.
  8. 8Obligation 7 — Protocol adaptation — New evidence must change treatment duration, level of care, or escalation when indicated. — Evidence: continued infusion, revised orders, ICU transfer, transplant-center consultation.
  9. 9Obligation 8 — Discontinuation criteria verified — Treatment may stop only when the applicable clinical and laboratory criteria are demonstrably satisfied. — Evidence: undetectable or appropriately resolved acetaminophen level, improving hepatic markers, stable clinical condition, documented toxicology rationale.
  10. 10Obligation 9 — Complication escalation — Evidence of hepatic failure or worsening injury must create new obligations for critical care and transplant evaluation. — Evidence: escalation record, consultation acceptance, transfer documentation.
  11. 11Obligation 10 — Discharge and prevention plan — Once medically resolved, the patient must receive medication-safety education and psychiatric or social assessment when the exposure was intentional or circumstances require it. — Evidence: discharge plan, behavioral-health evaluation, medication counseling, follow-up acceptance.
  12. 12Obligation 11 — Closure verified — The case closes only when toxicologic risk, treatment, complications, and downstream safety obligations have been addressed.

Constitutional observations

Constitutional lesson

A protocol endpoint is not the same as obligation closure. Treatment is complete only when current evidence demonstrates that the clinical obligation has been satisfied.

What The Engine makes visible

Conventional systems can show: acetylcysteine was started; the standard infusion sequence finished; laboratory tests were ordered; the patient remained stable. Those facts do not demonstrate that treatment was safe to stop. The Engine asks: Was antidote discontinuation supported by the patient’s current evidence, or merely by completion of the nominal protocol? That is the accountability center of the case. The prescription has a scheduled endpoint. The obligation does not. The obligation ends only when the evidence supports closure. Constitutional-property mapping This case clearly exercises: CP-003 — Dynamic Obligation Creation CP-005 — Evidence-Dependent Obligation Gating CP-007 — Distributed Obligation Convergence It also strongly reinforces the behavior already observed in Pain Medicine and Sleep Medicine: Continuing or stopping treatment requires renewed evidentiary justification. But here the issue is more acute. The decision to discontinue treatment is itself gated by evolving evidence. Operational Readiness? There is a superficial resemblance: Is the patient ready for antidote discontinuation? But that would stretch Operational Readiness beyond its current boundary. Existing CP-005 adequately explains why discontinuation cannot proceed until the evidence is satisfied. No Operational Readiness flag is needed. Opportunity Preservation? Early antidote treatment preserves the opportunity to prevent hepatic injury, but CP-003 and CP-005 already explain the accountability structure. We should not add another Opportunity Preservation observation merely because timing matters. Again, restraint is appropriate.

Constitutional relationships

Validated constitutional properties

Related specialties (shared properties)

Demonstration

No worked demonstration is provisioned for this specialty in this build. Occupational Medicine (Specialty 25) is the first domain and carries the worked demonstration; the constitutional architecture above is shared across specialties.